Skip directly to local search Skip directly to A to Z list Skip directly to navigation Skip directly to site content Skip directly to page options
CDC Home

Volume 5, Number 3—June 1999

Perspective

The Cost Effectiveness of Vaccinating against Lyme Disease

Martin I. MeltzerComments to Author , David T. Dennis, and Kathleen A. Orloski
Author affiliations: Centers for Disease Control and Prevention, Atlanta, Georgia, USA

Main Article

Figure 2

Average cost effectiveness of vaccinating a person against Lyme disease with changes in the cost of vaccination, probabilities of identifying and treating early Lyme disease, and probabilities of contracting Lyme disease. A negative value indicates that vaccinating a person will result in a net cost to society, while a positive value indicates a net savings to society. The results shown are the means from Monte Carlo simulations (see Table 1 and text for further details). Vaccine assumed 85% eff

Figure 2. Average cost effectiveness of vaccinating a person against Lyme disease with changes in the cost of vaccination, probabilities of identifying and treating early Lyme disease, and probabilities of contracting Lyme disease. A negative value indicates that vaccinating a person will result in a net cost to society, while a positive value indicates a net savings to society. The results shown are the means from Monte Carlo simulations (see Table 1 and text for further details). Vaccine assumed 85% effective (Table 1).

Main Article

Top of Page

 

Past Issues

Select a Past Issue:

Art in Science - Selections from Emerging Infectious Diseases
Now available for order



CDC 24/7 – Saving Lives, Protecting People, Saving Money. Learn More About How CDC Works For You…

USA.gov: The U.S. Government's Official Web PortalDepartment of Health and Human Services
Centers for Disease Control and Prevention   1600 Clifton Rd. Atlanta, GA 30333, USA
800-CDC-INFO (800-232-4636) TTY: (888) 232-6348 - Contact CDC–INFO